期刊文献+

p27Val109Gly基因多态性与肿瘤易感性的Meta分析 被引量:1

p27Val109Gly polymorphism and cancer risk:a systematic review and Meta-analysis
原文传递
导出
摘要 目的:通过Meta分析系统评价p27Val109Gly基因多态性与肿瘤易感性的关系。方法:检索PubMed、Medline、Web of Science和中国知网等数据库中研究p27Val109Gly基因多态性与肿瘤易感性关系的研究。运用Rev-Man5.0软件进行异质性检验、系统性评价和分层亚组分析,计算合并OR及95%CI;应用State 11.0软件进行定量发表偏倚检验。结果:共纳入13项研究,累计病例组4 894例,对照组5 413例。G等位基因携带者肿瘤总体易感性降低,OR=0.81,95%CI=0.66~0.99,P=0.04,尤其是前列腺癌(OR=0.60,95%CI=0.36~0.98,P=0.04)和食管癌(OR=0.34,95%CI=0.22~0.55,P<0.01)。剔除不符合或不能进行HWE检验的研究后,再次行Meta分析。结果显示,G等位基因与肿瘤易感性无相关性,OR=0.82,95%CI=0.64~1.03,P=0.09。高加索人群(OR=0.97,95%CI=0.84~1.12,P=0.67)和亚洲人群(OR=0.77,95%CI=0.57~1.02,P=0.07)、基于医院(OR=0.70,95%CI=0.42~1.17,P=0.17)和社区(OR=0.86,95%CI=0.67~1.11,P=0.24)的肿瘤患者,p27Val109Gly基因多态性与肿瘤易感性无明显相关性。结论:p27Val109Gly基因多态性G等位基因与肿瘤的易感性呈负相关,尤其是前列腺癌和食管癌。这种相关性在高加索人、亚洲人及对照组来源于医院或社区的患者中不显著。 OBJECTIVE: To investigate the association between p27Val109Gly polymorphism and cancer susceptibility. METHODS:We searched relevant articles from Pub med, Medline,Web of Science,CNKI database. We made systematicall and stratified evaluation by statistical analysis software RewMan5.0. We tested publication bias by State 11.0. RESULTS: Thirteen studies involving 4 894 cases and 5 413 controls were included. Total analysis found that G-allele could decrease susceptibility of all tumor (OR= 0.81,95% CI= 0.66 - 0.99, P = 0.04), specially prostate cancer (OR = 0.60, 95%CI=0. 36-0.98,P=0.04) and esophagus cancer (OR=0. 34,95%CI=0.22-0. 55,P〈0. 01). Re-analysis showed that there was no association(OR= 0.82,95% CI= 0. 64-1. 03 , P = 0.09) between the p27Val109Gly polymorphism and cancer risks. There was no association between Caucasian (OR=0.97,95%CI=0.84-1.12 ,P=0.67) and Asian (OR= 0.77,95%CI=0.57-1.02,P=0.07) in hospital-based (OR=0.70,95%CI=0.42-1.17,P=0.17) and populationbased (OR= 0.86,95% CI= 0.67-1.11 ,P=0.24) patients. CONCLUSION:G-allele of p27Val109Gly polymorphism may be related with the cancer risk,especially prostate cancer and esophageal cancer as a low-risk factor. This relevance is not notable in Caucasians, Asians and patients from hospital. [
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第17期1360-1365,共6页 Chinese Journal of Cancer Prevention and Treatment
关键词 P27 Val109Gly 基因多态性 肿瘤 易感性 META分析 p27 Val109Gly polymorphism tumor risk Meta-analysis
  • 相关文献

参考文献19

  • 1Teng EC, Todd LR, Ribar TJ, et al. Gfer inhibits Jabl-mediated degradation of p27kipl to restrict proliferation of hematopoietic stem cells[J]. Mol Biol Cell,2011,22(8) : 1312-1320.
  • 2李作生,李保庆,王国臣.p21和p27基因多态性与女性肺癌的关联研究[J].河北医药,2010,32(3):272-275. 被引量:4
  • 3杨娟,郑青山.Meta分析的统计学方法[J].中国临床药理学与治疗学,2005,10(11):1309-1314. 被引量:58
  • 4Kibel AS, Suarez BK, Belani J, et al. CDKN1 A and CDKN1 B pol- ymorphisms and risk of advanced prostate carcinoma[J]. Cancer Res,2003,63(9) :2033-2036.
  • 5韦凤,陈巍魏,许晶,聂伟伟,王丽,陈龙邦,管晓翔.p27^(Kip1)基因V109G多态性与乳腺癌易感性的Meta分析[J].临床肿瘤学杂志,2012,17(1):24-27. 被引量:2
  • 6Li G, Sturgis EM, Wang LE, et al. Association between the V109G polymorphism of the p27 gene and the risk and' progression of oral squamous cell carcinoma[J]. Clin Cancer Res, 2004, 10 (12) : 3996- 4002.
  • 7李作生,马玉泉,李保庆,张云杰,张月峰,李勇.p21和p27基因多态性与非小细胞肺癌的相关性研究[J].中华肿瘤防治杂志,2007,14(14):1046-1049. 被引量:3
  • 8Figueiredo JC, Knight JA, Cho S, et aL Polymorphisms cMyc-NllS and p27-V109G and breast cancer risk and prognosis[J].BMC Canc- er,2007,7: 99.
  • 9Onay VU,Briollais L,Knight JA, et al. SNP-SNP interactions in breast cancer susceptibility[J]. BMC Cancer, 2006,6:114.
  • 10Berry KJ,Johnston JE, Mielke PW Jr. An alternative measure of effect size for Cochran's Q test for related proportions[J]. Per- cept Mot Skills,2007,104(3) :1236-1242.

二级参考文献50

  • 1富振英.Meta-analysis方法介绍[J].卫生研究,1995,24(6):380-382. 被引量:7
  • 2郭炜,崔雅静,方淑梅,李琰,王娜,张健慧.p21^(cip1)和p27^(kip1)基因遗传多态与食管癌及贲门癌发病风险的关联[J].癌症,2006,25(2):194-199. 被引量:6
  • 3管晓翔,陈龙邦.肿瘤细胞p27^(kip1)蛋白错位分布和低表达的分子机制[J].中华肿瘤防治杂志,2006,13(10):786-789. 被引量:11
  • 4Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988,16:1215.
  • 5Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cipl is a potent inhibition of G1 cyclin-dependent kinases. Cell, 1993,75 : 805-816.
  • 6Li G, Liu Z, Sturgis EM, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 2005, 26 : 1596-1602.
  • 7Kibel AS, Suarez BK, Belani J, et al. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Res, 2003, 63: 2033-2036.
  • 8Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell, 1994, 78 : 59-66.
  • 9Tomoda K, Kubota Y, Kato J. Degradation of the cyclindependent-kinase inhibitor p27Kipl is instigated by Jabl. Nature, 1999, 398:160-165.
  • 10Naidu R, Hat YC, Taib NA. P27 V109G polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res, 2007, 26 : 133-140.

共引文献68

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部